2021 | 2020 | 2019 | 2018
MEDIA INQUIRIES Media@BriiBio.com

Dec 03, 2019

Brii Biosciences Expands Therapeutic Focus to Include Neurosciences with Addition of John Kraus, M.D., Ph.D.

- Dr. Kraus to lead newly-created Neurosciences Therapy Area
- Zhijian Chen, Ph.D., named Strategic Scientific Advisor

more

Nov 21, 2019

Brii Biosciences Expands Infectious Disease Pipeline

-Three partnerships focused on novel programs for treatment-resistant bacterial infections and diseases
-Company pipeline now includes up to 12 partnered assets, in addition to internal development programs
-Infectious disease focus will address disproportional unmet need in China and support global public health

more

Nov 14, 2019

VBI Vaccines and Brii Biosciences Initiate Phase 1b/2a Study of BRII-179 (VBI-2601) in Patients with Chronic Hepatitis B Infection

-Novel recombinant, protein-based immuno-therapeutic for the treatment of chronic hepatitis B virus (HBV) infection
-Two-part, dose-escalation study expected to enroll up to 65 patients 
-Initial data expected in H2 2020

more

up
×